Polypill: an affordable strategy for cardiovascular disease prevention in low–medium-income countries
Therapeutic Advances in Cardiovascular Disease · 2018-06 · 12 (6) · 169-174
DOI: 10.1177/1753944718764588 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 16.03.2018. Verfasst von Patricio López-Jaramillo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias de la Salud, Universidad de Santander (UDES), Bucaramanga, Colombia Facultad de Ciencias de la Salud Eugenio Espejo, Universidad…. Hauptthemen laut MEDLINE: Drug Costs, Income. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The simplification of fixed dose medications by using a single ‘polypill’ is an attractive strategy to improve adherence to medications which has shown benefit to cardiovascular risk factor control and cardiovascular disease prevention or delay in the progression of these diseases. We review the evidence obtained from a series of clinical trials demonstrating an improvement in adherence to the polypill compared to the use of each compound separately, and found similar or better control of the classical cardiovascular risk factors and a similar safety profile. These results suggest that the use of the polypill could have a beneficial impact in cardiovascular morbidity and mortality. Furthermore, the polypill has the potential to improve cost effectiveness and is simple to use. However, before recommending the implementation of the polypill in programs aimed at primary and secondary cardiovascular prevention, we are awaiting the results of several current clinical trials aimed at measuring the impact on the frequency of major cardiovascular outcomes, particularly in low–medium-income countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias de la Salud, Universidad de Santander (UDES), Bucaramanga, Colombia Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador.
- Research Institute, Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia.
- Research Institute, Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia Medical School, Universidad Libre, Cali, Colombia.
ORCID-Profile: Patricio López-Jaramillo
Zitieren
APA
López-Jaramillo, P., González-Gómez, S., Zarate-Bernal, D., Serrano, A., Atuesta, L., Clausen, C., Castro-Valencia, C., Camacho-Lopez, P., & Otero, J. (2018). Polypill: an affordable strategy for cardiovascular disease prevention in low–medium-income countries. Therapeutic Advances in Cardiovascular Disease, 12(6), 169-174. https://doi.org/10.1177/1753944718764588
Vancouver
López-Jaramillo P, González-Gómez S, Zarate-Bernal D, Serrano A, Atuesta L, Clausen C, et al. Polypill: an affordable strategy for cardiovascular disease prevention in low–medium-income countries. Therapeutic Advances in Cardiovascular Disease. 2018;12(6):169-174. doi:10.1177/1753944718764588
BibTeX
@article{LpezJaramillo2018,
author = {López-Jaramillo, Patricio and González-Gómez, Silvia and Zarate-Bernal, Diego and Serrano, Andrés and Atuesta, Leonor and Clausen, Christian and Castro-Valencia, Claudia and Camacho-Lopez, Paul and Otero, Johanna},
title = {Polypill: an affordable strategy for cardiovascular disease prevention in low–medium-income countries},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2018},
volume = {12},
number = {6},
pages = {169--174},
doi = {10.1177/1753944718764588}
}
EUVIMED